Fundraising Fox
Somagenetix
Zurich, CH · 11 employees on LinkedIn · 2 known investors
Find your way into Somagenetix
Sign up to see every warm intro you have to Somagenetix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Somagenetix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Somagenetix is a gene therapy company that develops treatments for genetic diseases, particularly phagocyte-driven immune and neurodegenerative disorders, by correcting DNA at its source. Founded as a spin-out of the University of Zurich, the company aims to deliver one-time curative treatments for previously incurable genetic conditions.
Investors · 2
.jpeg){kind=logo}
How we know: Verve Ventures's portfolio page · funding news · press coverage · Not right? Tell us
How we know: VI Partners's portfolio page · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AOct 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Somagenetix do?
- Somagenetix is a gene therapy company that develops treatments for genetic diseases, particularly phagocyte-driven immune and neurodegenerative disorders, by correcting DNA at its source. Founded as a spin-out of the University of Zurich, the company aims to deliver one-time curative treatments for previously incurable genetic conditions.
- Who are Somagenetix's investors?
- Somagenetix's investors include Verve Ventures, VI Partners.
- Where is Somagenetix headquartered?
- Somagenetix is headquartered in Zurich, CH.